SPAC22F8.04 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped glycoproteins composed of two heavy chains and two light chains, with distinct constant (Fc) and variable (Fab) regions . The Fc region interacts with effector molecules (e.g., Fc receptors on immune cells) to mediate functions like phagocytosis or complement activation .

Antibody IsotypeKey FunctionRelevance
IgGCrosses placenta, long half-life, activates complementCritical for tumor immunotherapy
IgEBinds mast cells, mediates allergic responsesTargets parasites and allergens
IgMActivates classical complement pathwayForms pentamers for pathogen lysis

Antigen Cross-Presentation and DC Function

Dendritic cells (DCs) rely on Sec22b-dependent cross-presentation to activate CD8+ T cells against tumor antigens . Impaired Sec22b expression in DCs leads to reduced antitumor immunity and resistance to anti-PD-1 therapy . This mechanism underscores the importance of Fc-mediated interactions in immunotherapy:

  • Sec22b Role: Traffics antigens from phagosomes to the endoplasmic reticulum for cross-presentation .

  • Therapeutic Implications: Enhancing DC cross-presentation could improve checkpoint inhibitor efficacy .

IgG Purification and Functional Integrity

Low-pH purification methods (e.g., Protein G) can induce IgG aggregation, altering Fc receptor binding and effector functions . For example:

  • Protein G vs. Melon Gel: Protein G-purified IgG exhibits higher FcγRIIIa binding and phagocytosis activity due to aggregates .

  • Impact on Therapy: Aggregated IgG may enhance antibody-dependent cellular phagocytosis (ADCP) but risks off-target effects .

IgG Subclass-Specific Properties

IgG subclasses (IgG1–IgG4) exhibit distinct biological activities :

SubclassFcγR BindingHalf-LifeTherapeutic Use
IgG1Strong FcγRIIIa21 daysAnti-CD20 (rituximab)
IgG2Weak FcγRIIIa21 daysAnti-polysaccharide vaccines
IgG4Low FcγR binding21 daysAnti-inflammatory (e.g., natalizumab)

Antibody Glycosylation

Glycosylation at the Fc region modulates effector functions . For example:

  • Afucosylated IgG1: Enhances ADCP via increased FcγRIIIa binding .

  • High-mannose glycans: Promote complement activation .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC22F8.04 antibody; Uncharacterized transporter C22F8.04 antibody
Target Names
SPAC22F8.04
Uniprot No.

Target Background

Database Links
Protein Families
TPT transporter family
Subcellular Location
Membrane; Multi-pass membrane protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.